A Comparison of Change in Measured and Estimated Glomerular Filtration Rate in Patients with Nondiabetic Kidney Disease
Open Access
- 1 September 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of the American Society of Nephrology
- Vol. 3 (5), 1332-1338
- https://doi.org/10.2215/cjn.05631207
Abstract
Background and objectives: All glomerular filtration rate (GFR) estimating equations have been developed from cross-sectional data. The aims of this study were to examine the concordance between use of measured GFR (mGFR) and estimated GFR (eGFR) in tracking changes in kidney function over time among patients with moderately severe chronic kidney disease. Design, setting, participants, & measurements: A retrospective cohort study of subjects who had been enrolled in the MDRD Study A and who had two or more contemporaneous assessments of mGFR and eGFR (n = 542; mGFR range, 25 to 55 ml/min per 1.73 m2) during the chronic phase (month 4 and afterwards). mGFR was based on urinary iothalamate clearance; eGFR was based on the 4-variable MDRD Study equation. Temporal changes in GFR were assessed by within-subject linear regression of time on GFR. Results: Median follow-up time for all subjects was 2.6 yr; median number of GFR measurements was six. The eGFR slope tended to underestimate measured decrements in GFR. The absolute value of the difference in mGFR and eGFR slopes was ≤2 ml/min per 1.73 m2 per yr among 58.3% of subjects; the remainder of subjects had larger absolute differences. Among the 22 variables studied, none predicted a systematic difference between mGFR slope and eGFR slope. Conclusions: Although eGFR and mGFR exhibited similar relationships to 22 baseline variables, the overall bias seen in the full cohort suggests that clinicians and researchers should exercise caution when interpreting eGFR slope as a marker of progression of kidney disease.Keywords
This publication has 22 references indexed in Scilit:
- Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKDAmerican Journal of Kidney Diseases, 2008
- Validation of Creatinine-Based Estimates of GFR When Evaluating Risk Factors in Longitudinal Studies of Kidney DiseaseJournal of the American Society of Nephrology, 2006
- Monitoring Kidney Function in Type 2 Diabetic Patients With Incipient and Overt Diabetic NephropathyDiabetes Care, 2006
- Monitoring Kidney Function in Type 2 Diabetic Patients With Incipient and Overt Diabetic NephropathyDiabetes Care, 2006
- Comparison of Methods for Determining Renal Function Decline in Early Autosomal Dominant Polycystic Kidney DiseaseJournal of the American Society of Nephrology, 2006
- Simple Cystatin C–Based Prediction Equations for Glomerular Filtration Rate Compared with the Modification of Diet in Renal Disease Prediction Equation for Adults and the Schwartz and the Counahan–Barratt Prediction Equations for ChildrenClinical Chemistry, 2005
- Detection of Renal Function Decline in Patients with Diabetes and Normal or Elevated GFR by Serial Measurements of Serum Cystatin C ConcentrationJournal of the American Society of Nephrology, 2005
- A Comparison of Iothalamate-GFR and Serum Creatinine-Based OutcomesJournal of the American Society of Nephrology, 2004
- Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathyKidney International, 1996
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986